GSK(GSK)2025-01-14 17:56Key Points Company and Industry Overview 1. GSK as a Global Biopharma Company: GSK is a global biopharma company focused on the prevention and treatment of disease [3]. 2. Demerger and Biopharma Focus: GSK demerged its consumer business three years ago, creating a dedicated biopharma company with a clear focus on benefiting patients and shareholders [2]. Financial Performance 3. 2024 Sales and Profit Growth: In the first nine months of 2024, GSK delivered 9% sales growth and 19% core operating profit growth [3]. 4. Full-Year 2024 Guidance: GSK confirmed its guidance for full-year 2024, expecting sales growth of 7% to 9% and core operating profit growth of 11% to 13% [5]. Product Approvals and Outlook 5. Product Approvals and Growth Outlook: GSK expects to secure five product approvals in the coming year and remains highly confident in delivering the growth outlooks set for 2026 and 2031 [5].